Condition
Nephrotic Syndrome, Minimal Change
Total Trials
5
Recruiting
2
Active
3
Completed
0
Key Insights
Highlights
No notable highlights available yet
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 30/100
Termination Rate
0.0%
0 terminated out of 5 trials
Late-Stage Pipeline
40%
2 trials in Phase 3/4
Results Transparency
0%
0 of 0 completed with results
Key Signals
Data Visualizations
Phase Distribution
2Total
P 3 (1)
P 4 (1)
Trial Status
Unknown2
Recruiting2
Active Not Recruiting1
Clinical Trials (5)
Showing 5 of 5 trials
NCT07010250Recruiting
Epithelial Dysmetabolism and Renal Fibrosis in ANCA Vasculitis
NCT06635720Phase 3Active Not Recruiting
REduced-dose Steroid PrOtocol for Childhood Nephrotic SyndromE (RESPONSE)
NCT05505500Recruiting
Interview Study of Adult and Child Patients and Parents of Children With Swelling Due to Nephrotic Syndrome.
NCT03786263Unknown
CHILDNEPH The Canadian Childhood Nephrotic Syndrome Study
NCT02649413Phase 4UnknownPrimary
Adjusted Steroids Therapy in Childerens With Idiopathic Nephrotic Syndrome
Showing all 5 trials